CPIX vs LIN · rev $10.4M vs P/E 34, rev $33.99B
Cumberland Pharmaceuticals Inc (CPIX) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CPIX currently screens at market cap $86.9M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CPIX and LIN stock pages for the full models.
Not investment advice.